Weiss, J. M., Bagley, S., Hwang, W., Bauml, J., Olson, J. G., Cohen, R. B., . . . Langer, C. (2016). Capecitabine and lapatinib for the first‐line treatment of metastatic/recurrent head and neck squamous cell carcinoma. Cancer, 122(15), 2350-2355. https://doi.org/10.1002/cncr.30067
Chicago Style (17th ed.) CitationWeiss, Jared M., Stephen Bagley, Wei‐Ting Hwang, Joshua Bauml, Juneko Grilley Olson, Roger B. Cohen, David Neil Hayes, and Corey Langer. "Capecitabine and Lapatinib for the First‐line Treatment of Metastatic/recurrent Head and Neck Squamous Cell Carcinoma." Cancer 122, no. 15 (2016): 2350-2355. https://doi.org/10.1002/cncr.30067.
MLA (9th ed.) CitationWeiss, Jared M., et al. "Capecitabine and Lapatinib for the First‐line Treatment of Metastatic/recurrent Head and Neck Squamous Cell Carcinoma." Cancer, vol. 122, no. 15, 2016, pp. 2350-2355, https://doi.org/10.1002/cncr.30067.